Patents Assigned to Geistlich Pharma
  • Publication number: 20130189199
    Abstract: A dental care preparation in a form of a toothpaste or tooth gel dentifrice includes an antimicrobial amount of at least one antimicrobial N-methylol transfer agent, and at least one of a fluoride compound or a source of fluoride ions.
    Type: Application
    Filed: September 26, 2011
    Publication date: July 25, 2013
    Applicant: GEISTLICH PHARMA AG
    Inventors: Rolf W. Pfirrmann, Peter Geistlich
  • Patent number: 8491592
    Abstract: An application device for bone substitute material is disclosed. A cylinder contains a piston rod having an elastically deformable piston. The cylinder is closed via an attachment, through which a wetting liquid phase can be inserted via an injection opening. After a period of time, the wetted bone substitute material is compressed, with excess liquid phase being pressed out through drainage openings. Thereafter, the attachment can be removed and if applicable discharging takes place through a curved discharge nozzle, with the piston being able to adapt itself to the curvature with the benefit of total emptying of the device.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: July 23, 2013
    Assignee: Geistlich Pharma AG
    Inventor: Werner F. Dubach
  • Publication number: 20130089606
    Abstract: It now has been found that oral administration of pharmaceutical agents, including N-methylol transfer agents such as Taurolidine may be used to provide efficacious blood plasma concentration of the agents for treatment of diseases by providing release of the active agent into the duodenum or jejunum of a patient and/or at a pH of about 5.4 to about 6.5. Embodiments of the invention therefore provide oral dosage forms, compositions and methods for administration of pharmaceutical agents to the duodenum or jejunum of a patient, and/or which release at a pH of about 5.4 to about 6.5.
    Type: Application
    Filed: June 1, 2011
    Publication date: April 11, 2013
    Applicant: GEISTLICH PHARMA AG
    Inventors: Rolf W. Pfirrmann, Peter Geistlich
  • Publication number: 20130011463
    Abstract: An implant for repair of a cartilaginous defect in a subject includes a collagen matrix charged with synovial cells. A method preparing an implant for repair of a cartilaginous defect in a subject includes obtaining a fluid containing synovial cells and charging the synovial cells to the matrix. A device for preparing a cell-charged implant includes a first chamber and a second chamber, the first and second chambers being separated by a membrane and a perforated filter. The membrane is adapted to collect cells from a cell-containing fluid introduced into the first chamber and the perforated filter is adapted to permit passage or diffusion of the fluid through the second chamber. A method for preparing a cell-charged implant utilizes the device.
    Type: Application
    Filed: September 13, 2012
    Publication date: January 10, 2013
    Applicant: GEISTLICH PHARMA AG
    Inventors: Birgit SCHAEFER, Lothar SCHLOESSER
  • Publication number: 20120130506
    Abstract: The invention relates to: a biphasic calcium phosphate/hydroxyapatite (CAP/HAP) bone substitute material comprising a sintered CAP core and at least one uniform and closed epitactically grown layer of nanocrystalline HAP deposited on top of the sintered CAP core, whereby the epitactically grown nanocrystals have the same size and morphology as human bone mineral, i.e. a length of 30 to 46 nm and a width of 14 to 22 nm, a process of preparing the above CAP/HAP bone substitute material comprising the steps of a) preparing a sintered CAP core material, b) immersing the sintered CAP core material in an aqueous solution at a temperature between 10° C. and 50° C.
    Type: Application
    Filed: June 15, 2010
    Publication date: May 24, 2012
    Applicant: GEISTLICH PHARMA AG
    Inventor: Michael Alexander Bufler
  • Publication number: 20120083790
    Abstract: An application device for bone substitute material is disclosed. A cylinder contains a piston rod having an elastically deformable piston. The cylinder is closed via an attachment, through which a wetting liquid phase can be inserted via an injection opening. After a period of time, the wetted bone substitute material is compressed, with excess liquid phase being pressed out through drainage openings. Thereafter, the attachment can be removed and if applicable discharging takes place through a curved discharge nozzle, with the piston being able to adapt itself to the curvature with the benefit of total emptying of the device.
    Type: Application
    Filed: September 30, 2011
    Publication date: April 5, 2012
    Applicant: Geistlich Pharma AG
    Inventor: Werner F. Dubach
  • Publication number: 20110274756
    Abstract: Tissue regeneration or grafting is promoted utilizing a structure including a multi-layer sheet of collagen membrane material which includes a purified collagen barrier sheet material derived from natural collagen-containing tissue, the barrier sheet material including a barrier layer with an outer smooth barrier face and a fibrous face opposite the smooth barrier face. The structure further includes a matrix layer of collagen sponge material adjacent to the fibrous face. The matrix layer of collagen sponge material is resorbed by a body of a subject at a substantially faster rate than the barrier sheet material.
    Type: Application
    Filed: January 18, 2010
    Publication date: November 10, 2011
    Applicant: GEISTLICH PHARMA AG
    Inventors: Peter Geistlich, Lothar Schloesser
  • Publication number: 20110270394
    Abstract: Skin regeneration or grafting is promoted utilizing a structure including a multi-layer sheet of collagen membrane material which includes a purified collagen barrier sheet material derived from natural collagen-containing tissue, the barrier sheet material including a barrier layer with an outer smooth barrier face and a fibrous face opposite the smooth barrier face. The structure further includes a matrix layer of collagen sponge material adjacent to the fibrous face. The matrix layer of collagen sponge material is resorbed by a body of a subject at a substantially faster rate than the barrier sheet material.
    Type: Application
    Filed: January 18, 2010
    Publication date: November 3, 2011
    Applicant: GEISTLICH PHARMA AG
    Inventors: Alan S. Herford, Lothar Schloesser, Peter Geistlich
  • Publication number: 20090163479
    Abstract: The invention provides a method of inhibiting tumor growth in a mammal, by administering to the mammal composition containing taurolidine, taurultam, or a biologically active derivative thereof. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death by apoptosis.
    Type: Application
    Filed: December 12, 2008
    Publication date: June 25, 2009
    Applicant: GEISTLICH PHARMA AG
    Inventors: Paul Calabresi, James Darnowski